Drug Discovery & Development
News on drug screening, clinical trials, companion diagnostics, immunotherapy, & personalized therapies in genetics, genomics, and molecular diagnostics.
Sorrento Therapeutics, National Institute of Genomic Medicine of Mexico to Form SARS-CoV-2 Alliance
The partners will work together on a range of products for the diagnosis and treatment of SARS-CoV-2, which will be commercialized in Mexico.
The digital pathology firm is working to further develop its diagnostic capabilities and broaden its menu of algorithms for different diseases.
Caris Life Sciences, Elevation Oncology Team on Targeted Drug Development
The companies are working together to mine Caris' multiomic data for new cancer drug targets, sharing drug/diagnostic development costs for chosen candidates.
Tasso Gets CE Mark for At-Home Blood Collection Device
The Tasso-M20 device was designed for the collection, storage, and transport of blood samples for analyzing drug levels or monitoring biomarkers.
Burning Rock Biotech, Abbisko Therapeutics Ink CDx Partnership for ABSK091
Burning Rock will use its sequencing platform to identify urothelial carcinoma patients with FGFR alterations, supporting development of Abbisko's drug.